GitaThanarajasingamMD

PubMed

• Patterns of progression after immune checkpoint inhibitors for Hodgkin lymphoma: implications for radiation therapy.
  Jessica F Burlile, Kelsey M Frechette, William G Breen, Steven R Hwang, Alexandra S Higgins, Adrienne N Nedved, William S Harmsen, Sydney D Pulsipher, Thomas E Witzig,...> ;Blood Advances. 2024 Mar 12
• Rechallenge With High-Dose Methotrexate After Treatment With Glucarpidase in Adult Patients With Lymphoma.
  Truong, H., Barreto, J., Mara, K., Hampel, P., Micallef, I., Nowakowski, G., Thanarajasingam, G., Thompson, C., Wang, Y., Witzig, T., Herrmann, S., Leung, N.> ;JCO Oncology Practice. 2024 Feb 26
• [Special issue PRO] Considering endpoints for comparative tolerability of cancer treatments using patient report given the estimand framework.
  Peipert, J., Breslin, M., Calvert, M., Cella, D., Smith, M., Roydhouse, J., Basch, E., Thanarajasingam, G.> ;Journal of Biopharmaceutical Statistics. 2024 Feb 15
• Integrating 4 methods to evaluate physical function in patients with cancer (In4M): protocol for a prospective cohort study.
  Thanarajasingam, G., Kluetz, P., Bhatnagar, V., Brown, A., Cathcart-Rake, E., Diamond, M., Faust, L., Fiero, M., Huntington, S., Jeffery, M., Jones, L., Noble, B., Pal...> ;BMJ Open. 2024 Jan 10
• 1 citations
  The Timing, Trajectory, and Incidence of Immune-Related Adverse Events in NSCLC Treated With Atezolizumab.
  Pritzl, S., Yu, W., Bara, I., Kaul, M., Williams, K., Dueck, A., Smith, K., Thanarajasingam, G., Mansfield, A.> ;JTO Clinical and Research Reports. 2023 Dec 1
• Critical gaps in understanding treatment outcomes in adolescents and young adults with lymphoma: A review of current data.
  Priyanka A Pophali, Lindsay M Morton, Susan K Parsons, David Hodgson, Gita Thanarajasingam, Carrie Thompson, Thomas M Habermann, Kerry J Savage> ;Ejhaem. 2023 Nov 1
• 2 citations
  Time to progression of disease and outcomes with second-line BTK inhibitors in relapsed/refractory mantle cell lymphoma.
  Diego Villa, Aixiang Jiang, Carlo Visco, Nicola Crosbie, Rory McCulloch, Michael J Buege, Anita Kumar, David A Bond, Jonas Paludo, Matthew J Maurer, Gita Thanarajasing...> ;Blood Advances. 2023 Aug 22
• 17 citations
  Patient-Reported Outcomes During and After Treatment for Locally Advanced Rectal Cancer in the PROSPECT Trial (Alliance N1048).
  Ethan Basch, Amylou C Dueck, Sandra A Mitchell, Harvey Mamon, Martin Weiser, Leonard Saltz, Marc Gollub, Lauren Rogak, Brenda Ginos, Gina L Mazza, Brian Colgrove, Geor...> ;Journal of Clinical Oncology. 2023 Jul 20
• 5 citations
  Patient-Reported Outcomes, Digital Health, and the Quest to Improve Health Equity.
  Joshua C Pritchett, Debra Patt, Gita Thanarajasingam, Anne Schuster, Claire Snyder> ;American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2023 Jun 1
• 1 citations
  Integrating 4 Measures to Evaluate Physical Function in Patients with Cancer (In4M): Protocol for a prospective study.
  Gita Thanarajasingam, Paul G Kluetz, Vishal Bhatnagar, Abbie Brown, Elizabeth Cathcart-Rake, Matthew Diamond, Louis Faust, Mallorie H Fiero, Scott F Huntington, Molly ...> ;Medrxiv. 2023 Mar 9
• Bayesian penalized likelihood PET reconstruction impact on quantitative metrics in diffuse large B-cell lymphoma.
  Jason R Young, Geoffrey B Johnson, Eric C Ehman, Annie T Packard, Andrew C Homb, Mark A Nathan, Gita Thanarajasingam, Bradley J Kemp, Mugu, V.> ;Medicine. 2023 Feb 10
• 2 citations
  Wearable sensor-based performance status assessment in cancer: A pilot multicenter study from the Alliance for Clinical Trials in Oncology (A19_Pilot2).
  William A Wood, Deepika Dilip, Andriy Derkach, Natalie S Grover, Olivier Elemento, Ross Levine, Gita Thanarajasingam, John A Batsis, Charlotte Bailey, Arun Kannappan, ...> ;PLOS Digital Health. 2023 Jan 1
• 5 citations
  Central nervous system involvement by mantle cell lymphoma.
  Nicole McLaughlin, Yucai Wang, Thomas Witzig, Jose Villasboas, Thomas Habermann, David Inwards, Nora Bennani, Gita Thanarajasingam, Grzegorz Nowakowski, Luis Porrata, ...> ;Leukemia & Lymphoma. 2023 Feb 1
• 13 citations
  Inclusion of a core patient-reported outcomes battery in adolescent and young adult cancer clinical trials.
  Michael E Roth, Susan K Parsons, Patricia A Ganz, Lynne I Wagner, Pamela S Hinds, Sarah Alexander, Kristin Bingen, Sharon L Bober, Julienne Brackett, David Cella, N Ly...> ;Journal of the National Cancer Institute. 2023 Jan 10
• 1 citations
  High-Dose Methotrexate in Patients With Lymphoma: Predictors of a Complicated Course.
  Darragh F O'Donoghue, Huong L Truong, Heidi D Finnes, Jennifer S McDonald, Heather P May, Stephen M Ansell, N Nora Bennani, Thomas M Habermann, David J Inwards, Patric...> ;JCO Oncology Practice. 2022 Dec 1
• 2 citations
  Causes of death in low-grade B-cell lymphomas in the rituximab era: a prospective cohort study.
  Aung M Tun, Arushi Khurana, Raphael Mwangi, Brian K Link, Yucai Wang, Andrew L Feldman, Carrie A Thompson, Anne J Novak, Jose C Villasboas, Gita Thanarajasingam, Umar ...> ;Blood Advances. 2022 Sep 13
• 7 citations
  An Exploratory Analysis of the "Was It Worth It?" Questionnaire as a Novel Metric to Capture Patient Perceptions of Cancer Treatment.
  Gita Thanarajasingam, Ethan Basch, Carolyn Mead-Harvey, Antonia V Bennett, Gina L Mazza, Gisela Schwab, Jessica Roydhouse, Lauren J Rogak, Amylou C Dueck> ;Value in Health. 2022 Jul 1
• 88 citations
  Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer: A Randomized Clinical Trial.
  Ethan Basch, Deborah Schrag, Sydney Henson, Jennifer Jansen, Brenda Ginos, Angela M Stover, Philip Carr, Patricia A Spears, Mattias Jonsson, Allison M Deal, Antonia V ...> ;JAMA. 2022 Jun 28
• 3 citations
  Methodological standards for using the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) in cancer clinical trials.
  Ethan Basch, Gita Thanarajasingam, Amylou C Dueck> ;Clinical Trials. 2022 Jun 1
• 23 citations
  Nivolumab in patients with relapsed or refractory peripheral T-cell lymphoma: modest activity and cases of hyperprogression.
  N Nora Bennani, Hyo Jin Kim, Levi D Pederson, Pamela J Atherton, Ivana N Micallef, Gita Thanarajasingam, Grzegorz S Nowakowski, Thomas Witzig, Andrew L Feldman, Stephe...> ;Journal for Immunotherapy of Cancer. 2022 Jun 1
• 1 citations
  Patient Experience in Clinical Trials: Quality of Life, Financial Burden, and Perception of Care in Patients With Multiple Myeloma or Lymphoma Enrolled on Clinical Tri...
  Surbhi Sidana, Cristine Allmer, Melissa C Larson, Amylou Dueck, Kathleen Yost, Rahma Warsame, Gita Thanarajasingam, James R Cerhan, Jonas Paludo, S Vincent Rajkumar, T...> ;JCO Oncology Practice. 2022 Aug 1
• 17 citations
  Longitudinal Patient Reported Outcomes with CAR-T Cell Therapy Versus Autologous and Allogeneic Stem Cell Transplant.
  Surbhi Sidana, Amylou C Dueck, Gita Thanarajasingam, Joan M Griffin, Carrie Thompson, Urshila Durani, Michelle Burtis, Rahma Warsame, Jonas Paludo, Morie A Gertz, Ange...> ;Transplantation and Cellular Therapy. 2022 Aug 1
• 7 citations
  Reaching beyond maximum grade: progress and future directions for modernising the assessment and reporting of adverse events in haematological malignancies.
  Gita Thanarajasingam, Lori M Minasian, Vishal Bhatnagar, Franco Cavalli, R Angelo De Claro, Amylou C Dueck, Tarec C El-Galaly, Neil Everest, Jan Geissler, Christian Gi...> ;The Lancet. Haematology. 2022 May 1
• Correction to: Missing data strategies for the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Alliance A091105 ...
  Gina L Mazza, Molly M Petersen, Brenda Ginos, Blake T Langlais, Narre Heon, Mrinal M Gounder, Michelle R Mahoney, Alexander J Zoroufy, Gary K Schwartz, Lauren J Rogak,...> ;Quality of Life Research. 2022 Apr 1
• 8 citations
  Outcomes in primary cutaneous diffuse large B-cell lymphoma, leg type.
  Robert M. Kraft, Stephen M. Ansell, Jose C. Villasboas, N. Nora Bennani, Yucai Wang, Thomas M. Habermann, Gita Thanarajasingam, Scott C. Lester, William R. Macon, Davi...> ;Hematological Oncology. 2021 Aug 28
• Join now to see all

Abstracts/Posters

• Patient Experience of Chimeric Antigen Receptor (CAR)-T Cell Therapy Vs. Stem Cell Transplant: Longitudinal Patient Reported Adverse Events, Cognition and Quality of Life
  Gita Thanarajasingam, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• A Phase II Study of Nivolumab in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma
  Gita Thanarajasingam, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Treatment and Lifestyle Risk Factors for Cardiovascular Disease Post Lymphoma Diagnosis: A Prospective Study in the Modern Treatment Era
  Gita Thanarajasingam, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

• Longitudinal toxicity analysis with novel summary metrics of lenalidomide maintenance in follicular lymphoma in ECOG-ACRIN 2408. 
  2019 ASCO Annual Meeting - 6/1/2019